Commentary on the AHRQ report on research on meditation practices in health.
Journal of alternative and complementary medicine (New York, N.Y.) December 1, 2008 DOI: 10.1089/acm.2008.0464 (opens in new tab) via PubMed
Summary
AI-generated from the abstractDouble blinding is not an appropriate control for placebo in meditation research. A viable alternative is to make treatment and control groups equivalent on nonspecific therapeutic attention factors and expectation. High quality meditation research must also use qualified instructors, have high compliance levels, ensure proficient practice, use state-of-the-art measurement methodology, and ensure control subjects are not inadvertently practicing meditation. The AHRQ report did not assess these determinants of research quality. A wide range of study designs have demonstrated that the traditional goal of meditation, a state of inner silence called 'transcendental consciousness,' has unique physiological characteristics with implications for health, cognition, and behavior.
Study at a glance
| Characteristics | Commentary Randomized Peer reviewed |
|---|---|
| Key finding | Argues that double blinding is not an appropriate control for placebo in meditation research and that future reviews should include studies demonstrating the unique physiological characteristics of transcendental consciousness. |
Abstract
The Agency for Healthcare Research and Quality (AHRQ) report is a major reference point for establishing where the research on meditation stands and where it should go from here. This commentary argues that double blinding, a major component of the report's evaluation criteria, is not an appropriate control for placebo in meditation research. A viable alternative is to make the treatment and control groups equivalent on nonspecific therapeutic attention factors and expectation. High quality meditation research must also use qualified instructors, have high compliance levels, insure proficient practice, use state-of-the-art measurement methodology, and make sure control subjects are not inadvertently practicing the same or another form of meditation. None of these determinants of research quality was assessed by the AHRQ report. It is noteworthy that whereas randomized controlled trials have their place in demonstrating clinical efficacy, few if any of the major ideas in the basic or behavioral sciences have come from randomized trails. A wide range of study designs have demonstrated that the traditional goal of meditation, a state of inner silence called "transcendental consciousness," has unique physiological characteristics with far ranging implications for health, cognition, and behavior. Such studies need to be included in future reviews of meditation techniques.